Earplugs and Eye Masks for Reducing Delirium
Earplugs and Eye Masks Worn at Night to Reduce the Incidence of Delirium in General Medicine Inpatients
1 other identifier
interventional
12
1 country
1
Brief Summary
There has been some recent evidence to support the use of earplugs and eye masks to prevent delirium, but the existing studies have been small, have not been thoroughly replicated, and have only been conducted with intensive care unit (ICU) patients. Therefore, we propose to conduct a single-arm pilot study for an eventual single-blinded randomized controlled trial designed to assess the efficacy of earplugs and eye masks worn at night for prevention of delirium in a population of general medicine inpatients over the age of 65. The primary outcome will be incidence of delirium as measured by Confusion Assessment Method (CAM). In this pilot study, we will assess feasibility and will not perform any statistical comparisons. In the subsequent randomized controlled trial, we will be comparing the hazard rates on an intention-to-treat basis. Secondary outcomes will be exploratory and include length of stay, cost data, and use of pharmacologic interventions for sleep, delirium, or agitation. There are no physical risks and no cost to the subjects in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2018
CompletedFirst Posted
Study publicly available on registry
March 20, 2018
CompletedStudy Start
First participant enrolled
August 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 8, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2018
CompletedNovember 5, 2021
October 1, 2021
4 months
March 14, 2018
November 3, 2021
Conditions
Outcome Measures
Primary Outcomes (9)
Incidence of delirium
Will be assessed using the CAM
The first 5 days of patients' hospitalization
Feasibility as measured by number of patients screened
5 days
Feasibility as measured by number of patients ineligible
5 days
Feasibility as measured by number of patients who decline to participate
5 days
Feasibility as measured by number of patients who dropped out of the study
5 days
Feasibility as measured by number of patients who wore the earplugs
5 days
Feasibility as measured by number of patients who wore the eye masks
5 days
Feasibility as measured by number of CAM assessment days
5 days
Feasibility as measured by number of patients who successfully completed the study
5 days
Study Arms (1)
Earplugs and eye masks
EXPERIMENTALInterventions
Patients in this study will be given earplugs and eye masks to be worn during sleep
Eligibility Criteria
You may qualify if:
- Admitted to General Medicine (units 8100 and 8300 only) from the Duke University Hospital (DUH) Emergency Department
- Age \>= 65
You may not qualify if:
- Admitted from outside hospitals, clinics (i.e., direct admissions), or transferred from another department
- Admitted as "observation" (i.e., expected length of stay \< 2 nights)
- Admitted \> 24 hours prior to time of enrollment
- Non-English-speaking patients will be excluded because a language barrier would introduce inaccuracy into the CAM measurement and for feasibility reasons (e.g., availability of translator services)
- Blind or deaf patients will be excluded because they are unlikely to benefit from the intervention, but sensory-impaired patients will be included
- Patients lacking decision-making capacity for whom no Legally Authorized Representative (LAR) is available
- Primary reason for admission "altered mental status", drug withdrawal, stroke, or seizure
- Patients for whom a withdrawal pathway has been preemptively initiated based on their substance use history (e.g., the alcohol withdrawal pathway order set or other as needed ("PRN") orders for the indication of withdrawal)
- Delirium present at time of enrollment
- Glasgow Coma Scale (GCS) \< 10 at time of enrollment
- Enrolled in this trial during a previous admission (i.e., we will not resample)
- Enrolled in a separate trial this admission
- Contraindication to using earplugs or an eye mask (e.g., facial trauma or other safety concern)
- Significant fall risk per nursing assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Health System
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juliessa Pavon, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2018
First Posted
March 20, 2018
Study Start
August 6, 2018
Primary Completion
December 8, 2018
Study Completion
December 8, 2018
Last Updated
November 5, 2021
Record last verified: 2021-10